Related Experiment Video
Updated: Jun 26, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Pediatric N-Methyl-d-Aspartate (NMDA) Receptor Encephalitis, With and Without Herpes Encephalitis
1Division of Pediatric Neurology, Department of Pediatrics, Children's Hospital of Alabama, 9968University of Alabama at Birmingham, Birmingham, AL, USA.
Insights
Children with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and prior herpes simplex encephalitis (HSE) showed distinct clinical features and received less immunotherapy than those without HSE. Infant outcomes in the HSE+NMDAR group reflected HSE sequelae.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neurological disorder.
- Herpes simplex encephalitis (HSE) is a viral infection of the brain that can have long-term consequences.
- Understanding the interplay between prior HSE and subsequent NMDAR encephalitis is crucial for diagnosis and management.
Purpose of the Study:
- To compare clinical, diagnostic, management, and outcome factors in pediatric patients with NMDAR encephalitis who had a history of HSE versus those without.
- To identify differences in presentation, treatment, and prognosis between these two groups.
Main Methods:
- Retrospective review of pediatric patients with anti-NMDAR antibodies in cerebrospinal fluid between 2012 and 2019.
- Patients were divided into two groups: those with a history of HSE (HSE+NMDAR) and those without (NMDAR-only).
- Demographic, clinical, immunotherapy, and outcome data were collected and compared.
Main Results:
- Six of 17 patients had a history of HSE; 5 were infants, presenting younger than the NMDAR-only group.
- Seizures were more common in HSE+NMDAR patients (100%) compared to NMDAR-only patients (73%).
- HSE+NMDAR patients received significantly less immunotherapy (median 1) than NMDAR-only patients (median 4.5).
Conclusions:
- Clinical presentation and treatment intensity differ between pediatric NMDAR encephalitis with and without a history of HSE.
- Outcomes in infants with HSE and subsequent NMDAR encephalitis appear to be primarily influenced by the sequelae of HSE.
- Further research is needed to elucidate the specific mechanisms and optimize management strategies for these complex cases.
Objective:
To compare clinical, diagnostic, management, and outcome factors in children with anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis and a history of herpes simplex encephalitis (HSE) to children with NMDAR encephalitis without a history of HSE.
Methods:
All patients with anti-NMDAR antibodies in cerebrospinal fluid treated at our institution between 2012 and 2019 were identified and divided into those with a history of HSE (HSE+NMDAR group) and those without a history of HSE (NMDAR-only group). Demographic data, clinical characteristics, immunotherapy, and outcome data were collected on all patients and compared between the 2 groups.
Results:
Seventeen patients were identified with anti-NMDAR antibodies in cerebrospinal fluid, 6 of whom had a history of HSE. Mean age in the HSE+NMDAR cohort was significantly younger in the HSE+NMDAR cohort, as 5 of the 6 patients were infants. Of HSE+NMDAR patients, 50% had behavioral symptoms, 67% had movement disorders, and 100% had seizures at disease nadir. In the NMDAR-only group, 100% had behavioral symptoms, 73% had movement disorders, and 73% had seizures at nadir. HSE+NMDAR patients received a median of 1 immunotherapy, compared to a median of 4.5 immunotherapies in the NMDAR-only group.
Conclusion:
Behavioral symptoms were more common in NMDAR-only patients, whereas seizures were more common in HSE+NMDAR patients. Both groups had significant disability at disease nadir, with more improvement in disability over time in the NMDAR-only group. HSE+NMDAR patients received fewer immunotherapies than NMDAR-only patients. Outcomes of infants with HSE appear to primarily reflect sequelae from HSE.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Rocky Mountain Spotted Fever
Viral Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology